Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2003
04/03/2003WO2002032414A3 Ribavirin-pegylated interferon alfa hcv combination therapy
04/03/2003WO2002024909A9 Receptor nucleic acids and polypeptides
04/03/2003WO2002024742A3 Atp-binding cassette protein
04/03/2003WO2002024723A9 Modified factor viii
04/03/2003WO2002022174A9 A novel cationic lipopolymer as biocompatible gene delivery agent
04/03/2003WO2002022166A9 Tweak receptor agonists as anti-angiogenic agents
04/03/2003WO2002018582A9 62112, a novel human dehydrogenase and uses thereof
04/03/2003WO2002018556A9 8797, a human galactosyltransferase and uses thereof
04/03/2003WO2002018544A9 Method and reagents for treatment of skin disorders by modulating the notch pathway
04/03/2003WO2002017852A3 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
04/03/2003WO2002014369A9 Human kininogen d5 domain polypeptides and their use
04/03/2003WO2002013846A3 Antifungal combination therapy
04/03/2003WO2002013808A3 Treatment of tumors with acetylenes distributed with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents
04/03/2003WO2002012524A3 Adenovirus e1b-55k single amino acid mutants and methods of use
04/03/2003WO2002010357A3 Gsk3 polypeptides
04/03/2003WO2002010214A3 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
04/03/2003WO2002009642A9 Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel
04/03/2003WO2002000860A3 Novel proteases
04/03/2003WO2001072782A9 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
04/03/2003US20030066096 Comprises encapsulated green fluorescent protein, blue fluorescent protein, and/or phycobiliprotein; for use in toys, paints, slimy play material, textiles (clothing), bubbles, ballons, cosmetics, bath powders, lotions, and foods
04/03/2003US20030065193 Antiinflammatory agents; antihistamines; antidiabetic agents
04/03/2003US20030065185 Antiinflammatory agents
04/03/2003US20030065160 Secreted protein HEMAE80
04/03/2003US20030065155 Probe for use as diagnostic tool in the detection of single nucleotide polymorphisms
04/03/2003US20030065151 Secreted protein HCEJQ69
04/03/2003US20030065149 Stabilized hemoglobin solutions
04/03/2003US20030065147 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030065143 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030065142 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer and nervous system disorders
04/03/2003US20030065140 Novel proteins and nucleic acids encoding same
04/03/2003US20030065139 Nucleotide sequences coding polypeptide for use in the treatment immunological, inflammatory, nervous system and cancer disorders
04/03/2003US20030065138 Linear gamma-carboxyglutamate rich conotoxins
04/03/2003US20030065137 Immunological methods to modulate myostatin in vertebrate subjects
04/03/2003US20030065136 Cyclic peptide for use in the treatment of inflammatory and autoimmune disease
04/03/2003US20030065026 Synergistic mixture with metal compound
04/03/2003US20030064996 Anticarcinogenic agents, antiinflammatory agents, anticholesterol agents, antidiabetic agents
04/03/2003US20030064984 Anticancer agents; side effect reduction
04/03/2003US20030064977 Viricides
04/03/2003US20030064949 Anticancer agents
04/03/2003US20030064948 Invasomes for therapy of disorders, their preparation and use
04/03/2003US20030064947 Polypeptides; induction immunology response; cancer diagnosis
04/03/2003US20030064946 Modulation of gene expression; respiratory system disorders
04/03/2003US20030064945 Modulation of gene expression; anticancer agents
04/03/2003US20030064944 Controlling cell differentiation, cell proliferation
04/03/2003US20030064943 High affinity TGFbeta nucleic acid ligands and inhibitors
04/03/2003US20030064942 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
04/03/2003US20030064934 Concurrent administering of druh and hypotonic sugar solution
04/03/2003US20030064932 Methods of treatment comprising administration of Substance P
04/03/2003US20030064930 Administering angiostatin
04/03/2003US20030064929 Modulating body/cranial hair growth
04/03/2003US20030064928 Therapeutic preparations for inhalation
04/03/2003US20030064927 Regeneration of soft tissue; wound healing agents
04/03/2003US20030064926 Angiostatin fragments and method of use
04/03/2003US20030064925 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064923 Autoimmune disease; antiarthritic agents; genetic engineering
04/03/2003US20030064922 G-CSF conjugates
04/03/2003US20030064919 Novel polypeptides and polynucleotides encoding same
04/03/2003US20030064918 Administering amylin; osteoporosis
04/03/2003US20030064917 Methods and compositions for inhibiting angiogenesis
04/03/2003US20030064916 Antigen peptides; medical diagnosis
04/03/2003US20030064915 Synthetic peptides to treat an autoimmune demylinating disease e.g., multiple sclerosis; an amino acid sequence having two tyrosine residues and a lysine complex with the myelin basic proteing to modulate an immune response
04/03/2003US20030064914 Copolymer-1 improvements in compositions of copolymers
04/03/2003US20030064522 Diagnosisng ischemia in humans; obtain sample, detect and measure concentration of ischemic marker, compare to control, evaluate for ischemic injury
04/03/2003US20030064514 Oligonucleotide for use as antiproliferative agent
04/03/2003US20030064499 Enzymatic polypeptide for use in the design of viricides
04/03/2003US20030064498 Genetic engineered, glycosylated and/or phosphorylated proteins for diagnosing and treating disorders related to this novel human protein
04/03/2003US20030064495 Human polynucleotides encoding proteins that share sequence similarity with animal kinases; gene expression
04/03/2003US20030064494 Novel isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD and use of the said SOD in cosmetic, food, and pharmaceutical compositions
04/03/2003US20030064492 Nucleotide sequences for use as tool in human therapeutics and diagnostics
04/03/2003US20030064490 Nucleotide sequences coding polypeptide for use as therapeutic, diagnostic, nutritional and cosmetic tools
04/03/2003US20030064489 Polypeptides for use in the treatment of cancer and nervous system disorders
04/03/2003US20030064482 Preparation of antiproliferative agent; obtain chemical intermediates, insert into reaction mixture, heat, remove protective groups, recover antiproliferative agent
04/03/2003US20030064481 Soluble protein for use in treatment of allergenic and autoimmune diseases
04/03/2003US20030064480 Soluble fusion protein for use in the treatment of blood, liver and kidney disorders
04/03/2003US20030064479 Helical cytokine zalpha33
04/03/2003US20030064476 Identification and characterization of a gene which protects cells from programmed cell death and uses therefor
04/03/2003US20030064470 Ligand for use as tool in the treatment of tumors in humans
04/03/2003US20030064439 Nucleotide sequences coding polypeptide for use in the treatment of schizophrenia and alzheimer's diseases
04/03/2003US20030064438 Nucleotide sequences coding polypeptide for use in the treatment and prevention of blood, immunological, cardiovascular, nervous system, sex, lung and gastrointestinal disorders
04/03/2003US20030064433 Human ion channels
04/03/2003US20030064431 Complement receptor type 1 (cr1)-like sequences
04/03/2003US20030064430 Novel steroid-activated nuclear receptors and uses therefor
04/03/2003US20030064426 Expression vector for use in the treatment of cancer and age-related defects
04/03/2003US20030064418 Protein for use in the diagnosis and treatment of cancer
04/03/2003US20030064413 Compositions and methods useful in avidity therapy
04/03/2003US20030064412 123 human secreted proteins
04/03/2003US20030064411 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease
04/03/2003US20030064410 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids
04/03/2003US20030064408 Protein-protein interactions
04/03/2003US20030064407 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064397 Transmembrane protein differentially expressed in prostate and lung tumors
04/03/2003US20030064383 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer
04/03/2003US20030064381 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer, nervous system, sexual, urogenital, viral and cushing's disease
04/03/2003US20030064378 Compositions and methods relating to lung specific genes and proteins
04/03/2003US20030064375 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of kidney, nervous system and arthritic disorders
04/03/2003US20030064369 Novel proteins and nucleic acids encoding same
04/03/2003US20030064367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064360 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
04/03/2003US20030064121 For use as dietary supplement, in drugs, soy protein concentrate
04/03/2003US20030064116 To enhance the nutritional value of the food consumed by mammals including humans and animals
1 ... 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 ... 3163